Navigation Links
Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same
Date:5/25/2013

Since high dose rate brachytherapy for prostate cancer is a temporary implant there is no radioactive source left in the patient. Cesium 131 is still a permanent seed implant with the same limitations compared to high dose rate brachytherapy. The Cesium 131 seeds are all of uniform strength so it is very difficult to get uniformity of dose with proper spacing of the seeds. The seeds are implanted into deformable tissue and once the seed is implanted it can’t be moved. The dose plan is still done as an estimated pre-plan prior to surgery or on the fly with “real time intra-operative planning” at the time of surgery. In either case the doses are calculated AFTER the implant. In contrast, with high dose rate brachytherapy the implant catheters and treatment positions are known and the dose can be designed in advance of the source delivery. The final treatment plan is completed and approved by the physician before rather than during or after the source is administered.

Dr. Hill notes that other disadvantages of a permanent seed implant are unchanged by the type of isotope. There can be anatomic changes or migration of seeds during the time it takes the permanent seeds to emit the dose, the permanent seeds cannot be placed at the capsule because there is no anchoring tissue, there are prostate size limitations, the bony pubic arch may limit the implant, and so on.

Although Cesium 131 appears to have an advantage over other permanent seed isotopes, in Dr. Hill’s opinion the overall advantage still goes to temporary interstitial high dose rate brachytherapy.

About Dennis R. Hill MD

Dr. Hill has been doing High Dose Rate Brachytherapy exclusively since 2004. He has done over five hundred High Dose Rate Prostate Brachytherapy implants and has published scholarly art
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors
2. Althea Technologies Appoints Dr. Dennis Fenton As Chairman Of Its Scientific Advisory Board
3. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
4. Urologists Debunk Misleading, Grossly Inaccurate Prostate Cancer Biopsy Study
5. Urologists Outraged over Government Panels Recommendation to Stop Life-Saving Prostate Cancer Testing
6. Exosome Diagnostics Presents Data at American Urology Association Demonstrating Potential Utility of Urine Exosomes to Non-invasively Detect and Manage Prostate Cancer
7. Gold nanoparticles could treat prostate cancer with fewer side effects than chemotherapy
8. Safeway Raises Over $9 Million to Fund Prostate Cancer Research
9. Genomic Health Announces Positive Topline Results of Large Prostate Cancer Clinical Validation Study; Company to Proceed with 2013 Commercial Launch
10. Prostate Cancer Medical Websites: Friend Or Foe?
11. University of College London Hospitals (UCLH) Selects GEO SCAN Medical as New Standard of Care for the Detection and Treatment of Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  CASI Pharmaceuticals, Inc. ... the acquisition, development and commercialization of innovative therapeutics addressing ... market with a commercial focus on China ... and 12 months ended December 31, 2014.  ... million), or ($0.05) per share, for the three months ...
(Date:3/26/2015)... CA (PRWEB) March 26, 2015 PRC ... (CRO), announced today several management and executive appointments effective ... Chief Financial Officer (CFO) and member of the Board ... of Business Operations, and Sue Dowden will assume the ... co-founder and current Chief Operations Officer (COO), has been ...
(Date:3/26/2015)... -- BioNano Genomics, Inc., the leader in genome mapping, announced ... commercial officer. Salyer has more than 20 years of ... sciences. At BioNano, Salyer will oversee the commercialization of ... assemble a comprehensive view of complex genomes to help ... located in the United States , ...
(Date:3/26/2015)... 26, 2015 PAREXEL International Corporation ... clinical research organization , announced today that ... to acquire all of the business assets of ... provider of specialized pharmacovigilance services, based in ... detection, assessment, monitoring, and prevention of adverse ...
Breaking Biology Technology:CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 2BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 3PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 2PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 3PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 4
... 11 It,s natural to have,concerns before undergoing a ... will make things easier. According to Timothy Schwab, MD,chief ... help whether,you,re having an outpatient procedure or spending a ... for every person regardless of age to be,physically and ...
... Sinovac Biotech Ltd. (Amex:,SVA), a vaccine-focused biotech company in ... Meeting of Shareholders on Thursday, September 4,2008 at 9:00 ... at,No. 39 Shangdi Xi Road, Haidian District, Beijing, PRC ... shareholders of record as of August 1,2008 will be ...
... Aug. 11 /Xinhua-PRNewswire-FirstCall/ --,China Biologic Products, Inc. (OTC ... plasma-based pharmaceutical companies in the People,s,Republic of China ... conference,call at 8:30 a.m. EDT on Friday, August ... To participate in the live conference call, ...
Cached Biology Technology:SCAN Health Plan Offers Seniors Five Tips to Prepare for Surgery 2Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders 2China Biologic Products Announces Second Quarter 2008 Results Conference Call 2
(Date:3/20/2015)... 2015 Research and Markets ( ... "India Sensors Market Forecast and Opportunities 2020" ... sensor market is projected to grow at a ... electronics, automotive, industrial and healthcare sectors are the ... In addition, adoption of MEMS technology in sensors ...
(Date:3/20/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) ... Global Strategic Business Report" report to their offering. ... in US$ Thousands. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... Latin America . Annual estimates and ...
(Date:3/17/2015)... MedNet Solutions , a global ... management systems, is pleased to announce that company ... in Clinical Trials Southeast conference – March 24-25 ... forum for MedNet to showcase iMedNet , ... eClinical technology platform. We strongly encourage ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... O. Wilson and botanist Peter H. Raven will receive the ... York Academy of Sciences. Each will also deliver a public ... at 7:30 p.m. The award, presented by the International ... Linnean Society of London, recognizes individuals who have made significant ...
... lands is contaminating groundwater, streams, lakes and estuaries, ... to fish kills. Cost-effective approaches to removing ... before it reaches sensitive water bodies have been ... on the horizon. A recent scientific workshop on ...
... has shown strong potential as a large-scale, emission-free energy ... in thousands of fatalities annually. Migratory bats, such as ... with wind turbines as they fly their routes in ... not only impacts the immediate area, but is also ...
Cached Biology News:E.O. Wilson and Peter Raven to receive Linnaean Legacy Award at NYAS public event 2E.O. Wilson and Peter Raven to receive Linnaean Legacy Award at NYAS public event 3New way of removing excess nitrogen from the environment 2New way of removing excess nitrogen from the environment 3Slight change in wind turbine speed significantly reduces bat mortality 2
... choice of PDMS Stamps (3 PDMS micropatterned ... micron squares or 100 um x 10 ... lines, 3 PDMS nano-patterned stamps with depth ... pitch of 400 nm, or 3 PDMS ...
Request Info...
Sterile glass 5 mm beads that make spreading bacterial and yeast cultures easy. Can be washed, autoclaved and reused....
... supplied as 10X concentrated solutions. REact Buffer SetConsists ... the REact buffers and one 250 microl vial ... 1 ml vials of REact 1 Buffer four ... 1 ml vials of REact 3 Buffer and ...
Biology Products: